<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lederman, Lynne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">D'Hoore, Andre</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">More Research is Needed to Determine Optimal Therapies for Rectal Cancer</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">29-30</style></pages><abstract><style  face="normal" font="default" size="100%">Rectal cancer is treated with surgery, radiation therapy (RT), and neoadjuvant and adjuvant chemotherapy (CT); yet, the best way to sequence and combine these modalities is not yet known. This article discusses organ-sparing surgery in rectal cancer, the feasibility of intensifying preoperative RT, as well as preoperative therapy.</style></abstract><number><style face="normal" font="default" size="100%">22</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>